相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cells
Brian A. Walker et al.
BLOOD (2013)
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Jakob Loven et al.
CELL (2013)
Super-Enhancers in the Control of Cell Identity and Disease
Denes Hnisz et al.
CELL (2013)
A TC classification-based predictor for multiple myeloma using multiplexed real-time quantitative PCR
M. F. Kaiser et al.
LEUKEMIA (2013)
DELLY: structural variant discovery by integrated paired-end and split-read analysis
Tobias Rausch et al.
BIOINFORMATICS (2012)
Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma
Brian A. Walker et al.
BLOOD (2012)
Frequent PVT1 Rearrangement and Novel Chimeric Genes PVT1-NBEA and PVT1-WWOX Occur in Multiple Myeloma with 8q24 Abnormality
Hisao Nagoshi et al.
CANCER RESEARCH (2012)
The genetic architecture of multiple myeloma
Gareth J. Morgan et al.
NATURE REVIEWS CANCER (2012)
Mapping of Chromosome 1p Deletions in Myeloma Identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as Being Genes in Regions Associated with Adverse Survival
Kevin D. Boyd et al.
CLINICAL CANCER RESEARCH (2011)
Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma
W-J Chng et al.
LEUKEMIA (2011)
Initial genome sequencing and analysis of multiple myeloma
Michael A. Chapman et al.
NATURE (2011)
A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value
Brian A. Walker et al.
BLOOD (2010)
Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences
Jeremy Goecks et al.
GENOME BIOLOGY (2010)
Frequent Upregulation of MYC in Plasma Cell Leukemia
Laura Chiecchio et al.
GENES CHROMOSOMES & CANCER (2009)
Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context
Laura Chiecchio et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Foxo3-/- mice demonstrate reduced numbers of pre-B and recirculating B cells but normal splenic B cell sub-population distribution
Rochelle M. Hinman et al.
INTERNATIONAL IMMUNOLOGY (2009)
AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies
Marta Chesi et al.
CANCER CELL (2008)
Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumors
Ana Gabrea et al.
GENES CHROMOSOMES & CANCER (2008)
Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes
Anwar N. Mohamed et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas
P. Bertrand et al.
LEUKEMIA (2007)
Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma
L. Chiecchio et al.
LEUKEMIA (2006)
Age has a profound effect on the incidence and significance of chromosome abnormalities in myeloma
FM Ross et al.
LEUKEMIA (2005)
Heterogeneous pattern of chromosomal breakpoints involving the MYC locus in multiple myeloma
S Fabris et al.
GENES CHROMOSOMES & CANCER (2003)
Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors
H Avet-Loiseau et al.
BLOOD (2001)
Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia:: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myelome and the Groupe Francais de Cytogenetique Hematologique
H Avet-Loiseau et al.
BLOOD (2001)
Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma
JR Sawyer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Characterization of the human B cell RAG-associated gene, hBRAG, as a B cell receptor signal-enhancing glycoprotein dimer that associates with phosphorylated proteins in resting B cells
LK Verkoczy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
